Embryonic stem cells and Parkinson's Disease: Cell transplantation to cell therapy

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 3, 2008, Pages 163-164

  Hall, Vanessa Jane ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LEVODOPA;

BLASTOCYST; CELL THERAPY; CELL TRANSPLANTATION; DOPAMINERGIC NERVE CELL; DYSKINESIA; EDITORIAL; EMBRYONIC STEM CELL; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; MESENCEPHALON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; SPINAL CORD INJURY; SURVIVAL;

ANIMALS; CELL TRANSPLANTATION; EMBRYONIC STEM CELLS; FETAL TISSUE TRANSPLANTATION; HUMANS; PARKINSON DISEASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 42249108133     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Lim E. A walk through the management of Parkinson s disease. Ann Acad Med Singapore 2005;34:188-95.
2. Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 2001;60:741-52.
3. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-31.
4. Hall VJ, Li JY, Brundin P. Restorative cell therapy for Parkinson's disease: A quest for the perfect cell. Semin Cell Dev Biol 2007;18:859-69
5. Hagell P, Cenci MA. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res Bull 2005;68: 4-15.
6. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-9.
7. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-14.
8. Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 2004;22:1246-55.
9. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418: 50-6.
10. Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007;25: 918-28.
11. Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200-7.
12. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006;12:1259-68.
13. Cho YH, Kim DS, Kim PG, Hwang YS, Cho MS, Moon SY, et al. Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model. Biochem Biophys Res Commun 2006;341:6-12.
14. Yang D, Zhang ZJ, Oldenburg M, Ayala M, Zhang SC. Human embryonic stem cell-derived dopaminergic neurons reverse functional benefit in parkinsonian rats. Stem Cells 2008;26:55-63.
15. Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006;24:1433-40.
16. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003;23:780-5.
17. Parish CL, Parisi S, Persico MG, Arenas E, Minchiotti G. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. Stem Cells 2005;23:471-6.
18. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 2007;25:2257-68.
19. Bieberich E, Silva J, Wang G, Krishnamurthy K, Condie BG. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 2004;167:723-34.